Premium
Possible association of the alpha‐2A adrenergic receptor gene ( ADRA2A ) with symptoms of attention‐deficit/hyperactivity disorder
Author(s) -
Wang Bing,
Wang Yufeng,
Zhou Rulun,
Li Jun,
Qian Qiujin,
Yang Li,
Guan Lili,
Faraone Stephen V.
Publication year - 2006
Publication title -
american journal of medical genetics part b: neuropsychiatric genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.393
H-Index - 126
eISSN - 1552-485X
pISSN - 1552-4841
DOI - 10.1002/ajmg.b.30258
Subject(s) - proband , haplotype , attention deficit hyperactivity disorder , transmission disequilibrium test , allele , polymorphism (computer science) , population , genotype , linkage disequilibrium , medicine , genetics , gene , clinical psychology , biology , mutation , environmental health
A dysfunction of the central noradrenergic system has long been suggested to be involved in attention‐deficit/hyperactivity disorder (ADHD). Pharmacological evidence from animal studies and clinical practice has identified the alpha‐2A adrenergic receptor gene ( ADRA2A ) as a candidate gene in ADHD. Some findings from Caucasian populations seem to support a role for this gene in ADHD. The current study first examined the association of the ADRA2A MspI and DraI polymorphisms with ADHD in the Han Chinese population, which differs quite substantially from the Caucasian population in the frequencies of alleles at these polymorphisms. No biased transmission of alleles of either polymorphism was observed using transmission disequilibrium test (TDT) analysis in a sample of 268 nuclear families with an ADHD proband; however, haplotype analysis only identified a trend toward over‐transmission of the M/C haplotype to probands with the combined subtype of ADHD (χ 2 = 3.233, P = 0.072). The mm genotype of the MspI polymorphism was also marginally related ( P = 0.051) to lower ADHD symptom scores in a sample of 559 Chinese children with ADHD, which is inconsistent with data from Caucasian samples. Our results provide weak evidence for a possible role of ADRA2A in ADHD symptom expression. © 2006 Wiley‐Liss, Inc.